Cardiac conditions in pregnancy and the role of midwives: A discussion paper by Millington, S.K. et al.
722  |    Nursing Open. 2019;6:722–732.wileyonlinelibrary.com/journal/nop2
1  | INTRODUC TION
In 2018, the European Society of Cardiology reported a greater risk of 
cardiovascular disease (CVD) in pregnancy in the Western world. This 
was attributed to increasing age at first pregnancy and pregnancies 
in the late reproductive years (or between ages 40–50) that included 
comorbidities (Regitz‐Zagrosek et al., 2018). Historically, rheumatic 
heart disease (RHD) was a contributing factor for cardiac complica‐
tions in pregnancy; however, today women who have undergone sur‐
gery for complex congenital heart disease (CHD) or have who have 
acquired cardiac disease are at high risk (Johns, 2013). This does not 
imply that expectant women with heart disease cannot achieve an 
uncomplicated pregnancy; many women do so. Good care is facili‐
tated through appropriate preconception counselling and evaluation, 
when potential risks can be identified and discussed and, in some 
cases, through therapeutic interventions implemented to optimize the 
clinical status of mother and unborn child (Zöllner, Curry, & Johnson, 
2013). However, accurate diagnosis of cardiac disease in pregnancy 
remains complex, as the physiological changes in the cardiovascu‐
lar system during pregnancy mimic disease and, therefore, present 
a confusing clinical picture (Arafeh & Baird, 2006; Merrigan, 2009). 
Women with pre‐existent or newly diagnosed cardiac conditions dur‐
ing pregnancy require both physiological and psychological support 
to achieve the best outcome for both mother and baby (Revell, 2016).
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Abstract
Aim: This paper provides an overview of the two broad categories of cardiac condi‐
tions observed in pregnancy (congenital and acquired). It also identifies the midwives’ 
role in the childbirth continuum and includes assessment, track and trigger systems 
and management during labour and delivery.
Design: Discussion paper.
Methods: Data were collected by reviewing international evidence and by searching 
computerized databases.
Results: Research has identified that women with associated risk factors of a cardiac 
condition who delay pregnancy have an increased risk of experiencing cardiovascular 
complications in pregnancy with poorer outcomes. The Three Ps in a Pod clinical ini‐
tiative in the United Kingdom highlights working as a team in multidisciplinary pro‐
grammes to improve mothers’ care and save lives. Midwives play a key role during 
pregnancy and need to be appraised in relation to cardiovascular disease observed in 
pregnancy, its potential risks and anticipated problems and within the continuum of 
care.
K E Y W O R D S
advanced midwifery education, cardiovascular diagnosis, heart disease, pregnancy 
complications
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The psychological state of a mother may influence transient 
changes in their cardiovascular system during labour and deliv‐
ery, with emotions such as anxiety and fear linked to hypertension 
and increased vasoactive hormones (Nicholson et al., 2016; Revell, 
2016). Current research has identified that perinatal depression is 
an important risk factor for pregnancy‐associated CVD, particularly 
heart failure, and contributes to poorer outcomes, in turn (Nicholson 
et al., 2016). These women often require complex counselling, mul‐
tidisciplinary team follow‐ups and referral to a high‐risk maternity 
hospital. As such, midwives have an important educational and sup‐
portive role throughout a woman's pregnancy (Revell, 2016).
2  | AIMS OF THE STUDY
The aim of this paper was to update midwives with an overview 
of the cardiovascular conditions observed in pregnancy, highlight 
management and consider their role with the health of mother and 
baby. Indeed, it is a challenge for midwives to reconcile a culture of 
risk and the changing profile of women giving birth with the phi‐
losophy of midwifery and midwifery education, as advocated by the 
International Confederation of Midwives (ICM) (Bharj et al., 2016). 
Although the phenomena of respectful care and over‐medicalization 
reported in Bharj et al. (2016) are acknowledged, it will not be dis‐
cussed in the context of this paper. Instead, the focus is on midwives 
as among the first healthcare providers to see pregnant women 
and their role in conducting risk assessment and facilitating optimal 
management for women‐centred care (International Confederation 
of Midwives & Global Standards for Midwives Education, 2010). 
Research Ethics Committee approval was not required for this dis‐
cussion paper.
3  | BACKGROUND
3.1 | The significance of cardiovascular disorders in 
pregnancy
Cardiac conditions typically seen in pregnancy fall into two broad 
categories: congenital and acquired (Johns, 2013). Corrected CHD is 
the most prevalent cardiac condition and is generally well tolerated, 
although this is dependent on the specific type of cardiac defect. 
Factors that influence how well a mother and her baby tolerate preg‐
nancy include the maternal heart's functional status (i.e. the ven‐
tricular function), the severity of valvular disease and the presence 
of cyanosis or pulmonary hypertension (Johns, 2013). Cyanotic CHD 
in pregnant women also poses a significant risk for both mother and 
foetus, with a high incidence of stillbirth, preterm delivery and in‐
trauterine growth restriction (IUGR) (Yu‐Ling Tan, 2010).
During 2009 and 2014 in the UK, 189 women reportedly died from 
heart disease associated with or aggravated by pregnancy (Knight et 
al., 2016). Sudden arrhythmic cardiac death with normal hearts was 
the most common cause of heart disease‐related deaths (N = 53, 
35%), with ischaemia following (N = 34, 22%). Women who died and 
had pre‐existing cardiac problems comprised 17% of that sample, 
while 77% of women were not known to have cardiac problems. This 
is a reminder to be cognizant of the possibility of undiagnosed cardiac 
disease in pregnant or recently delivered women (Knight et al., 2016).
The same “confidential” report on acquired heart disease found 
that 34 women died from ischaemic‐related heart conditions, repre‐
senting 22% of 153 cardiac deaths between 2009–2014 (Cantwell et 
al., 2011; Knight et al., 2016). Further, there were 16 deaths as a result 
of atherosclerosis and 11 due to coronary artery dissection (Cantwell 
et al., 2011; Knight et al., 2016). Increased maternal age and pre‐ex‐
istent risk factors such as stress, smoking, obesity, high cholesterol, 
diabetes, hypertension and a family history of heart disease all con‐
tribute to the increased risk of atherosclerotic coronary artery dis‐
ease (CAD) associated with death in pregnancy (Burchill et al., 2015; 
Cantwell et al., 2011; Johns, 2013). Acquired cardiac conditions such 
as acute coronary syndrome (ACS), cardiomyopathies and arrhythmias 
also contribute to the global cause of complications in pregnancy and 
between 10 and 15% of indirect maternal mortality (Babic, Gabric, 
& Pintaric, 2011; Cantwell et al., 2011; Elkayam et al., 2014; Smith, 
Young, & Greer, 2008; Turitz & Friedman, 2014; Westhoff‐Bleck, 
Podewski, Hilfiker, & Hilfiker‐Kleiner, 2013). RHD remains a challenge 
in developing countries as a major cause of maternal mortality, mostly 
from severe mitral stenosis, with a mortality rate of up to 5% (Yu‐
Ling Tan, 2010). The latest Australian maternal data (dated between 
2008–2012) reported 16 deaths from CVD, four of which were from 
dissection of the aorta, four were due to cardiomyopathy and two 
were a consequence of myocardial infarction (Humphrey et al., 2015).
What does this paper contribute to the wider global 
clinical community?
Cardiac disease remains a major global cause of maternal 
mortality and morbidity. Accurate diagnosis of cardiac dis‐
ease in pregnancy remains complex, since physiological 
changes in the cardiovascular system during pregnancy 
mimic disease and, therefore, present a confusing clinical 
picture. This paper highlights the following:
• Midwives play a key role during pregnancy and need to 
be appraised of the CVD observed in pregnancy, its po‐
tential risks, anticipated problems and in terms of their 
role within the continuum of care.
• Midwives will often be the first healthcare providers to 
see pregnant women with cardiac disease and can facili‐
tate risk assessment and detection of these problems to 
ensure optimal management.
• There is also a potential role for midwives within the 
childbirth continuum to collaborate in multidisciplinary 
teams with ongoing surveillance; perform risk assess‐
ments; and ensure parental health education, maternal 
awareness and self‐management to optimize outcomes 
for both mother and baby.
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With significant changes to midwifery education programmes 
and clinical practice in Australia (which advocate the ICM philos‐
ophy of midwifery and that pregnancy and childbirth are normal 
physiological processes), it is no longer routine practice for midwives 
to undertake a comprehensive antenatal physical examination for 
pregnant women (Chalmers, Mangiaterra, & Porter, 2001; Tierney, 
Sweet, Houston, & Ebert, 2018). However, it is beneficial to provide 
additional education for midwives on cardiac history, as well as as‐
sessment to address specific clinical issues for RHD for Indigenous 
women and recent migrants, as a component of culturally sensitive 
antenatal care (Bharj et al., 2016; Clarke & Boyle, 2014). The fol‐
lowing sections detail the physiological cardiovascular adaptations 
during normal pregnancy, the track and trigger systems and labour 
and delivery information for midwives to consider in their practice.
3.2 | Cardiovascular adaptations 
during normal pregnancy
The following physiological changes present unique challenges 
for women who may be cardiac compromised in pregnancy (Ruys, 
Cornette, & Roos‐Hesselink, 2013):
1. The increased intravascular volume, which peaks in the third tri‐
mester, is a potential problem in women with obstructive cardiac 
lesions, such as mitral or aortic stenosis, or with impaired ventric‐
ular function (Roberts & Adamson, 2013).
2. A progressive decrease in systemic vascular resistance (SVR) in 
pregnancy enables the mean arterial pressure (MAP) to be pre‐
served despite an increase in cardiac output (CO). The MAP and 
systolic blood pressure (SBP) fall during pregnancy but returns to 
baseline in the late third trimester (Roberts & Adamson, 2013).
3. Marked fluctuations in CO during labour impose stress on an ex‐
pectant mother's compromised cardiovascular system. During 
pregnancy, the overall CO increases by 30% to 50% and can 
unmask previously asymptomatic cardiac diseases (Roberts & 
Adamson, 2013). The CO then peaks in the final stage of labour 
from 10 to 30 min (Hall, George, & Granger, 2011; Harris, 2011; 
Roberts & Adamson, 2013). This increase is attributed to auto‐
transfusion from the uterus and the venocaval release of volume 
in the lower extremities; however, the volume returns to the 
pre‐labour level within an hour of delivery. In women who have 
pre‐existent cardiac lesions with a fixed CO (i.e. pulmonary hyper‐
tension and mitral stenosis), adapting to these fluctuations may 
trigger clinical deterioration (Arafeh & Baird, 2006; Kaleschke & 
Baumgartner, 2011).
4. Hypercoagulability in pregnancy requires anticoagulation in 
women who have a high risk of arterial thrombosis and emboli‐
zation or have a prosthetic heart valve. The increase in the coag‐
ulation factors VII, VIII, X and XII and fibrinogen accompanied by 
decreased anticoagulatory and fibrinolytic activity during preg‐
nancy contribute to the prothrombotic state and increased risk 
of deep vein thrombosis. However, hypercoagulability in the peri‐
partum period acts as a protection mechanism for major blood 
loss during delivery for the mother (Cox, Gogarten, & Marcus, 
2005; Kaleschke & Baumgartner, 2011).
Table 1 provides a clinical reference of physiological changes that 
occur during pregnancy, highlighting the peak effect and potential risks.
4  | THE ROLE OF THE MIDWIFE
4.1 | Antenatal assessment during pregnancy
The midwives’ role includes obtaining pertinent medical and car‐
diac history in the antepartum period. Specific risk factors such as 
hypertension, pre‐eclampsia, smoking, obesity, diabetes, elevated 
Haemodynamic alterations
Time of 
peak effect Potential risks




Women with limited cardiac function or 
reserve may develop heart failure




Increased preload (central venous pressure 
or filling pressure) presents a problem for 
obstructed lesions (e.g. mitral or aortic 
stenosis) or ventricular dysfunction
Heart rate increased 10%–20% Third 
trimester
Tachycardia causes palpitations and impairs 
ventricular filling
Blood volume increased 40% 20–
24 weeks
Physiological “anaemia” of pregnancy due 
to less increase in erythrocyte mass
Peripheral vasodilation due to 
circulating oestrogen and 
direct arteriovenous connec‐




Decreases in both blood pressure and 
valvular regurgitation




Sensation of tachypnoea or dyspnoea
Source: Mendelson (2008); Roberts and Adamson (2013).
TA B L E  1   Physiological changes that 
occur during pregnancy, labour and 
delivery
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saturated fats and cholesterol that require referrals and ongoing 
self‐management need to be identified (Knight et al., 2016; Revell, 
2016). For example, a woman with a pre‐existent cardiac state 
may have received preconception counselling and, thus, be well in‐
formed; however, this is not always the case. Midwives need to be 
appraised of the “at‐risk” populations such as Indigenous people and 
immigrants, particularly those who are newly arrived or from African 
nations.
The potential problems with new or undiagnosed cardiac dys‐
function in pregnancy could be mitigated by midwives who are 
able to distinguish between normal and abnormal cardiovascular 
symptoms and initiate early referral and investigations (Roberts & 
Ketchell, 2012). This requires knowledge of pre‐existent cardiac 
conditions or conditions unmasked by the physiological changes in 
pregnancy (Knight et al., 2016). A recent UK‐based report empha‐
sized that women presenting repeatedly with cardiac symptoms and 
objective signs such as raised respiratory rate, persistent tachycar‐
dia and orthopnoea should be fully investigated (Knight et al., 2016). 
Examples of the cardiovascular symptoms observed in pregnancy 
are summarized in Table 2. The current track and trigger systems in 
clinical practice for midwives can improve recognition and response 
to clinical deterioration during pregnancy.
4.2 | Track and trigger systems
James, Endacott, and Stenhouse (2011) discussed the benefits of 
the current “track and trigger systems” that have been tailored to 
identify the altered physiology of pregnancy in the antepartum and 
intrapartum periods. Also known as the modified early obstetric 
warning system (MEOWS), this readily available tool empowers mid‐
wives to make good clinical judgements and recognize early clinical 
deterioration to escalate care (James et al., 2011). However, clinical 
effectiveness depends on accurate documentation of observations 
conducted at appropriate frequencies. The global trend has shifted 
“to examine severe maternal morbidity as well as mortality … to in‐
clude women who may be moving, undetected, along the morbidity–
mortality continuum” (James et al., 2011, p. 65)—and midwives are 
potentially ideal members of the multidisciplinary team to identify 
these women. However, this presents a challenge for midwives who 
may not have the clinical knowledge or skills to perform cardio‐
vascular assessment. Table 3 provides a quick reference guide for 
midwives detailing the cardiovascular assessment findings during 
pregnancy that warrant further investigation.
Knight et al. (2016) mandated ready access to an electrocar‐
diograph (ECG) machine and someone who can interpret ECGs as 
priority in consultant‐led maternity units. Specialist midwives and 
doctors who are skilled in 12‐lead ECG interpretation should know 
the changes in normal pregnancy. Left‐axis deviation is considered 
normal, while similarly inverted or flattened T waves may be and so 
do not require further investigation (Canobbio et al., 2017; James 
et al., 2011). Pertinent findings in normal pregnancy for chest X‐ray 
and 12‐lead ECG investigations are outlined in Table 4. The South 
Australian Perinatal Practice Guidelines recommend the New York 
Heart Association Functional Classification Criteria tool for predic‐
tion of maternal and neonatal outcomes. These guidelines are used 
when counselling prospective parents to determine the level of hos‐
pital care required (SA Health, 2014). Currently, the modified World 
Health Organization classification is the most accurate system of 
risk assessment for maternal cardiovascular complications (Regitz‐
Zagrosek et al., 2018).
4.3 | Labour and delivery
Midwives need to be cognizant that the haemodynamic changes 
during labour and delivery present potential challenges for women 
with heart disease; therefore, they need to anticipate and be pre‐
pared for sudden clinical deterioration. Repositioning mothers to a 
left lateral position to avoid compression of the inferior vena cava 
by the gravid uterus for women who experience supine syndrome 
is recommended for labour. However, this may be inappropriate for 
women with some specific cardiac conditions (Canobbio et al., 2017; 
McGregor, Barron, & Rosene‐Montella, 2015).
During each uterine contraction, a bolus of fluid is expelled into 
the intravascular space. Although it is transient and repetitive, for 
some at‐risk women, these changes may exacerbate underlying car‐
diac conditions. During labour, the CO increases by 15%–20% and 
SBP by 10% (Regitz‐Zagrosek et al., 2011). Concurrently, anxiety and 
pain stimulate the systemic nervous system to further elevate the 
SBP and heart rate (Canobbio et al., 2017; Harris, 2011). Physiological 
changes during labour affect various cardiac conditions differently, 
notably aortic diseases, obstructive valve disease and cardiomy‐
opathy. During the second stage of labour when women use the 
prolonged “Valsalva” manoeuvre, increasing blood pressure and af‐
terload can complicate aortic disease. Judicious management of fluid 
therapy and epidural anaesthesia may mitigate the risk of marked 
fluctuations in blood pressure that are detrimental to women with 
obstructive valve disease or cardiomyopathy (Arafeh & Baird, 2006; 
Roberts & Adamson, 2013).
Midwives recognize that delivery and management are tailored 
to a mother's specific cardiac state following a multidisciplinary 
team review. This team includes an obstetric high‐risk physician, a 
TA B L E  2   Cardiovascular symptoms observed in pregnancy
Due to pregnancy
Need to flag, as may represent 
cardiac disease





Dyspnoea, progressive, nocturnal 
or at rest
Dyspnoea Orthopnoea
Nocturia Chest pain, exertional or at rest
Chest pain  
Syncope, vasovagal Syncope, exertional
Source: Mendelson (2008, p. 7); Yu‐Ling Tan (2010, p. 108).
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cardiologist, an anaesthetist, an obstetrician and midwives (Curtis 
et al., 2009; SA Health, 2014). The proposed birth plan is also clearly 
documented, with vaginal delivery being the preferred mode and 
lower (uterine) segment caesarean section remaining limited to 
obstetric indications (Canobbio et al., 2017; Curtis et al., 2009). In 
instances of maternal collapse, both resuscitation and obstetric 
guidelines recommend that a perimortem caesarean delivery should 
be carried out within four minutes, but only if there is no return of 
spontaneous circulation with delivery of the foetus within five min‐
utes beyond 20 weeks’ gestation (McGregor et al., 2015; Soar et al., 
2010; Vanden Hoek et al., 2010). Table 5 summarizes the risks and 
commonly encountered problems during labour.
Pregnancy has been regarded as the ultimate cardiac stress test 
that a woman may experience in her life (Samuels‐Kalow & Funai, 
2007; Yu‐Ling Tan, 2010). The physiological changes increase the 
likelihood of a complicated pregnancy and birth in women with la‐
tent cardiac dysfunction (asymptomatic cardiac dysfunction) or 
a pre‐existent cardiac dysfunctional state. Thus, it is important to 
highlight the cardiovascular adaptations that exacerbate acquired 
cardiac conditions.
5  | CONGENITAL C ARDIAC CONDITIONS 
IN PREGNANCY
5.1 | Risks related to pregnancy and birth
The congenital defects that are likely to be problematic in pregnancy 
are complicated by pulmonary hypertension, cyanosis and severe 
left ventricular outflow tract obstruction, with cyanotic CHD pos‐
ing the most significant risk to both mother and foetus (Cantwell et 
al., 2011; Kaleschke & Baumgartner, 2011). Cyanosis worsens during 
pregnancy due to the increased cardiac workload, while polycythae‐
mia, hypoxaemia and cyanosis increase the risk of thromboembolic 
complications to 32% (van Mook & Peeters, 2008). Women with 
uncorrected cyanotic CHD also have increased cardiovascular ma‐
ternal complication rates of up to 30% (Elkayam, Goland, Pieper, & 
Silversides, 2016), which is precisely why midwives need to be aware 
that pregnancy will be discouraged when mothers have an oxygen 
saturation of less than 85%, a haematocrit above 60% and recur‐
rent syncope, due to maternal risk and a live birth rate of only 12% 
(Canobbio et al., 2017; Regitz‐Zagrosek et al., 2011). In particular, 
hypoxaemia is poorly tolerated by the foetus and is associated with 
a high incidence of foetal loss, stillbirths, preterm delivery and IUGR. 
In these cases, the risk to mother and unborn child correlates with 
the former's resting oxygen saturation (Cox et al., 2005; van Mook & 
Peeters, 2008; Zöllner et al., 2013).
5.2 | Congenital valvular heart disease
Mitral valve stenosis is the most common RHD valvular lesion ob‐
served in pregnancy to require invasive intervention such as open 
mitral valve commissurotomy or balloon valvuloplasty prior to or 
during gestation (van Mook & Peeters, 2008). Prophylactic antibiot‐
ics are administered in labour to women with valve disease or a his‐
tory of endocarditis or increased risk of sepsis, and the guarded use 
of oxytocin infusion during the third stage is recommended (Curtis 
et al., 2009; SA Health, 2014).
5.3 | Pulmonary hypertension or 
Eisenmenger syndrome
For women with pulmonary hypertension or Eisenmenger syndrome, 
the increasing cardiac pressure loads in pregnancy lead to right ven‐
tricular failure during the peri‐ and postpartum period and increase 
the maternal mortality rate to 30%–50% (Cox et al., 2005; Kempny 
TA B L E  3   Cardiovascular physical assessment findings during 
pregnancy
Due to pregnancy




(Pulse < 50 bpm)




(Pulse > 150 bpm)
Bounding pulses or collapsing 
pulse, dynamic precordium
Jugular venous distension
Loud first heart sound  
Third heart sound Cardiomegaly
Systolic murmur (mid‐ejection) at 
pulmonary area/lower left sternal 
edge
Right ventricular heave
Basilar rales Loud pulmonic component 
of S2
Peripheral oedema Summation gallop






Source: Mendelson (2008, p. 8); Yu‐Ling Tan (2010, p. 108)
TA B L E  4   Chest X‐ray and ECG findings in normal pregnancy
Chest X‐ray ECG
Straightened left heart border Leftward shift of QRS axis
Increased cardiothoracic ratio Small Q wave, inverted wave in 
lead III
Increased pulmonary vascular 
markings
ST segment and T wave 
changes
Small pleural effusions (early 
postpartum)
Atrial/ventricular ectopic
Source: Yu‐Ling Tan (2010, p. 108).
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et al., 2017). These women require a detailed delivery plan that con‐
siders the optimal timing and mode of delivery, postpartum intensive 
care and mechanical support and individualized support for many 
months postdelivery (Regitz‐Zagrosek et al., 2018). Further, primary 
pulmonary artery hypertension secondary to CHD is a contraindica‐
tion for pregnancy due to the poor prognosis for mother and baby, so 
termination is recommended (Canobbio et al., 2017; Gei & Montufar‐
Rueda, 2014; Johns, 2013).
TA B L E  5   Different diagnoses with corresponding risks and commonly encountered problems
Type of heart disease Most common complications Important information
Corrected CHD
Atrial septal defect Arrhythmias Uncorrected ASD ↑risk of pre‐eclampsia
Ventricular septal defect Premature delivery (12%) Uncorrected VSD ↑risk of pre‐eclampsia
Atrioventricular septal defect Arrhythmias (10%), deterioration of 
atrioventricular valve regurgitation (17%)
Reoccurrence of CHD (10%)
Tetralogy of Fallot Arrhythmias (6%) ↑Risk of progression to right ventricular dilation 
secondary to severe pulmonary regurgitation
Coarctation of the aorta Hypertensive disorders (11%) Increased risk of aortic dissection
Transposition of the great arteries 
(Mustard/Senning procedures)
Arrhythmias (22%), heart failure (11%) Irreversible ventricular dysfunction in 10%
Fontan operation Arrhythmias (16%), heart failure (4%) In case of cyanosis risk of miscarriage
Eisenmenger syndrome Heart failure (21%), maternal mortality 
(↑50%)
Mainly in postpartum period (first 3 days)
Valvular heart disease
Mitral stenosis Heart failure (31%), arrhythmias (11%) Mainly in patients with mitral valve <1.5 cm2
Aortic stenosis Heart failure (3%–44%), arrhythmias 
(6%–25%)
Mainly in patients with an aortic valve <1.5 cm2
Pulmonary stenosis Right‐sided heart failure (9%) Mainly in patients with moderate to severe 
pulmonary stenosis
Regurgitation lesions Heart failure (7%), supraventricular tachycar‐
dia (9%)
Mainly in patients with decreased cardiac 
function at baseline
Mechanical valves Valvular thrombus (↑10%), maternal mortality 
(↑4%)
Outcome depends on anticoagulation
Cardiomyopathy
Peripartum cardiomyopathy (current 
pregnancy)
Severe heart failure at the end of pregnancy 
(100%), maternal mortality (15%)
Complete recovery of ventricular function in half 
of the patients
Peripartum cardiomyopathy (previous 
pregnancy, minus abnormal ventricular 
function)
Recurrence of heart failure (21%) Ventricular function further decreases in some 
patients
Peripartum cardiomyopathy (previous 
pregnancy, plus abnormal ventricular 
function)
Recurrence of heart failure (44%), maternal 
mortality (20%)
Ventricular function further decreases in most 
patients
Dilated cardiomyopathy Heart failure (25%), arrhythmias (19%) Mainly in patients with abnormal ventricular 
function (LVEF < 45%) at baseline
Hypertrophic obstructive 
cardiomyopathy
Heart failure (28%) Mainly in symptomatic patients at baseline; 
beta‐blockers should be considered
Hypertrophic non‐obstructive 
Cardiomyopathy
Low risk of heart failure Mainly in symptomatic patients at baseline
Aortic disease
Marfan syndrome Aortic dissection (1%–10%) High risk in patients with aortic diameter> 45 mm
Bicuspid aortic valve disease Aortic dissection (<1%) High risk in patients with aortic diameter> 50 mm
Turner's syndrome Hypertensive disorders (67%), aortic 
dissection (5%)
Women with Turner's syndrome often not fertile
Ehlers–Danlos syndrome Maternal mortality (11.5%) ↑Risk of spontaneous uterine rupture
Pulmonary arterial hypertension Maternal mortality (17%–33%) Mainly in postpartum period (first 3 days)
Note. ASD, Atrial septal defect; LVEF, left ventricular ejection fraction; VSD, ventricular septal defect.Source: Ruys et al. (2013).
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6  | ACQUIRED C ARDIAC CONDITIONS IN 
PREGNANCY
Acquired cardiac conditions are undetected or latent conditions 
where the stress of pregnancy precipitates clinical deterioration of 
a woman's cardiac state. In the latest UK‐based report, these condi‐
tions included ACS, aortic dissection and peripartum cardiomyopa‐
thy (PPCM; Cantwell et al., 2011; Johns, 2013; Knight et al., 2016; 
Ruys et al., 2013).
6.1 | Acute coronary syndrome in pregnancy
ACS is an umbrella term that describes the spectrum of condi‐
tions resulting from a reduced coronary blood flow to the heart 
and range from acute myocardial ischaemia (unstable angina) 
to injury and necrosism, as seen in acute myocardial infarction 
(AMI) (Knight et al., 2016). ACS associated with the risk factors of 
smoking, hypertension, hyperlipidaemia, diabetes and family his‐
tory in pregnancy was reported in the UK (Borna, Neamatipoor, 
& Radman, 2012; Clegg & Macnab, 2013; Knight et al., 2016; 
Pepine et al., 2015), with pregnancy‐related risk factors such as 
pre‐eclampsia, eclampsia, postpartum infection, thrombophilia 
and blood transfusion known to increase the risk of AMI between 
three‐ and fourfold (Cantwell et al., 2011; Elkayam et al., 2014; 
Ruys et al., 2013).
The causes of AMI in pregnancy are classified into two broad 
categories of atherosclerotic (often with cardiovascular risk fac‐
tors) and non‐atherosclerotic, which includes coronary arterial 
dissection, thrombosis and coronary artery spasm (spontaneous 
or drug induced) (Wuntakal, Shetty, Ioannou, Sharma, & Kurian, 
2013). Merrigan (2009) stressed the need for recommendations 
to be implemented across multiple nurse settings to educate and 
guide staff on the care of pregnant women with AMI. Women with 
pre‐existent CAD have an increased risk throughout pregnancy and 
immediately postpartum. Often, their clinical presentation will be 
atypical of ischaemia, with dyspnoea, vomiting or dizziness pres‐
ent (Cantwell et al., 2011). Although AMI in pregnancy was once 
considered a rare occurrence, recent statistics indicate increased 
incidence, with a maternal death rate ranging between 20%–37% 
(Knight et al., 2016; Merrigan, 2009; Wuntakal et al., 2013). With 
a growing number of women delaying childbirth to later repro‐
ductive years, ischaemic cardiac disease is expected to become 
more prevalent (Roth & Elkayam, 2008; Turitz & Friedman, 2014). 
Thus, women with AMI require complex care by a multidisciplinary 
team that includes the assistance of capable midwives (Cantwell 
et al., 2011; Elkayam et al., 2014; Johns, 2013; Knight et al., 2016; 
Merrigan, 2009).
Management of AMI is primarily interventional cardiac proce‐
dures (i.e. percutaneous coronary intervention) with introduction of 
bare‐metal stents and/or coronary artery bypass surgery to improve 
coronary blood flow (Babic et al., 2011). The aim is to avoid the use 
of thrombolytics until after delivery because of the increased risk of 
heavy haemorrhage (Knight et al., 2016; Ruys et al., 2013).
6.2 | Aortic dissection
Aortic dissection, once considered rare in pregnancy, is now com‐
parable to PPCM. In a recent Australian maternal mortality report, 
there were four deaths due to dissection of the aorta and four due 
to cardiomyopathy between 2008–2012 (Humphrey et al., 2015). 
This condition is evident in women who are diagnosed with Marfan 
or Ehlers–Danlos syndrome (connective tissue disorders), a bicuspid 
aortic valve, coarctation of the aorta (and a previous repair) or hy‐
pertension (Cantwell et al., 2011; Johns, 2013; Yu‐Ling Tan, 2010). 
The exact precipitating cause is uncertain, but there is speculation 
that pregnancy predisposes women to aortic dissection because of 
the hormonal changes involved and the increased haemodynamic 
shear stress results in structural damage to vasculature (Zöllner et 
al., 2013). Midwives need to be cognizant of the fact that when a 
pregnant woman presents with severe chest, abdominal or back pain 
that requires opiate analgesia (excluding labour or postoperative 
pain), this warrants thorough investigation (Knight et al., 2016).
6.3 | Cardiomyopathies and heart failure
Cardiomyopathies in pregnancy include acquired and inherited 
diseases such as PPCM and toxic, hypertrophic, dilated, restrictive 
and idiopathic cardiomyopathies (Knight et al., 2016; van Mook & 
Peeters, 2008). Takotsubo syndrome, also known as “stress car‐
diomyopathy,” previously reported in postmenopausal women, is a 
now potential cause for acute heart failure (AHF) in birthing (Kucia, 
Dekker, & Arstall, 2015; Minatoguchi et al., 2014). In particular, 
Takotsubo syndrome is a cardiac condition that mimics ACS with no 
significant CAD seen on angiography, yet the characteristic balloon‐
ing of the left ventricle impairs the heart's ability to pump effec‐
tively and is evident on early echocardiogram (Brezina & Isler, 2008; 
Kucia, 2015; Lyon et al., 2016). Published cases describe Takotsubo 
syndrome as occurring soon after birthing and is associated with 
multiparity, preterm labour, caesarean delivery and 25% peripartum 
haemorrhage. It is less commonly associated with pre‐eclampsia and 
haemolysis, elevated liver enzymes and low platelet count syndrome 
(Kucia, 2015; Kucia et al., 2015). Importantly, early recognition of 
Takotsubo syndrome for referral to cardiology services helps ensure 
a full recovery is made and avoids inappropriate use of vasopressors, 
which have been considered counterproductive (Kucia, 2015).
6.4 | Peripartum cardiomyopathy
Women with AHF symptoms in the last month of pregnancy or up 
to six months’ postpartum, with the diagnosis of PPCM by exclu‐
sion, will arrive with breathlessness, orthopnoea and peripheral 
oedema (Johns, 2013; Knight et al., 2016). The multifactorial risk 
factors for PPCM are increased haemodynamic stress, advanced 
maternal age, multiparous pregnancies and/or multiple or teen‐
age pregnancies, African ethnicity, smoking, diabetes, hyperten‐
sion and pre‐eclampsia (Johns, 2013; Yu‐Ling Tan, 2010). Women 
who experience severe AHF and cardiogenic shock may require 
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urgent delivery, mechanical cardiovascular support (i.e. use of 
an intra‐aortic balloon pump or left ventricular assist device) and 
progress to heart transplantation (Knight et al., 2016). Midwives 
should know that subsequent pregnancies are considered high 
risk, regardless of whether a woman's left ventricular function has 
returned to normal. Therefore, these women require care in high‐
risk management facilities to address the increased risk of heart 
failure reoccurrence (Knight et al., 2016; van Mook & Peeters, 
2008).
6.5 | Mitral and aortic valve stenosis
Valvular disease in pregnancy is the result of RHD and the most 
common lesion mitral stenosis. If severe, the maternal mortal‐
ity increases up to 5%, with clinical deterioration evident in the 
third trimester or during labour and delivery (Johns, 2013; Yu‐
Ling Tan, 2010). Rheumatic mitral stenosis has an asymptomatic 
phase extending 10 to 20 years, so a woman's initial diagno‐
sis may occur during pregnancy due to the cumulative effect of 
tachycardia, increased blood volume and cardiac output, leading 
to cardiac decompensation. This results in tachyarrhythmia (rapid 
atrial fibrillation) or acute pulmonary oedema (Yu‐Ling Tan, 2010). 
Approximately 10% of women with significant aortic valve ste‐
nosis suffer a cardiac event in comparison with those with mild 
or moderate stenosis, who experience uneventful pregnancies 
(Canobbio et al., 2017). Aortic valve stenosis contributes to en‐
largement of the left ventricle, thus restricting the coronary blood 
supply and causing chest pain (angina pectoris). The key message 
for midwives is that for women with valvular disease, the presence 
of a tachyarrhythmia, such as newly acquired atrial fibrillation, af‐
fects cardiac function and may cause secondary pulmonary hyper‐
tension (Canobbio et al., 2017).
6.6 | Arrhythmias
Benign and problematic arrhythmias are observed increasingly 
in women with heart disease during pregnancy (Cantwell et al., 
2011; Knight et al., 2016). Bradyarrhythmias are well tolerated, 
but some women will require insertion of a pacemaker (Ruys et 
al., 2013). The risk of arrhythmias peaks during labour and deliv‐
ery when tachyarrhythmia (which is the most prevalent) requires 
prompt treatment using non‐teratogenic drug therapy or electri‐
cal therapy (Canobbio et al., 2017; van Mook & Peeters, 2008). 
Midwives will need to monitor closely the maternal heart rate dur‐
ing labour. In cases of women with pre‐existing histories of tach‐
yarrhythmia, the risk of exacerbation is 20% to 50%, regardless 
of whether one has structural heart disease (Regitz‐Zagrosek et 
al., 2011). Sustained tachyarrhythmia is not tolerated in women 
with structural heart disease or CHD so they require selective 
drug therapy that is not toxic to the foetus (Canobbio et al., 2017). 
Catheter ablation therapy of the node or an accessory pathway 
causing the arrhythmia may be performed prior to or following 
pregnancy (Regitz‐Zagrosek et al., 2011). Digoxin and β‐blocking 
agents are first choice of drug therapy in tachyarrhythmias, and 
if required, electrical cardioversion can be performed safely in 
pregnancy (Ruys et al., 2013). The most common antiarrhythmic 
amiodarone is foetotoxic and, therefore, is administered as a last 
resort (Regitz‐Zagrosek et al., 2011).
6.7 | Sudden arrhythmic death syndrome
According to the latest UK confidential enquiries, sudden arrhythmic 
death syndrome (SADS) has recently emerged as the most common 
cause of maternal cardiac death (38%) (Cantwell et al., 2011; Knight 
et al., 2016). Autopsies have shown no histopathological abnormali‐
ties of the heart to account for these women's deaths (Knight et al., 
2016). SADS has been defined as “sudden death in an adult for which 
no cause can be identified” (Zöllner et al., 2013, p. 92) and appears 
to be related to arrhythmias. Associated factors to consider are 
cardiac hypertrophy and obesity with a body mass index between 
30–45 (Regitz‐Zagrosek et al., 2011). Inherited arrhythmic disorders 
such as long QT syndrome increase the risk of sudden cardiac death, 
especially in the postpartum months; therefore, β‐blocking agents 
are recommended during and following pregnancy (Canobbio et 
al., 2017; Regitz‐Zagrosek et al., 2011). In view of increased CVD 
in pregnancy, we need to improve multidisciplinary collaboration, as 
emphasized in Knight et al. (2016). Alternatively, should we instead 
explore advanced practice roles such as specialist midwifery tailored 
to CVD? Indeed, as discussed in Multidisciplinary Management For 
Both Cardiac Groups7.3, midwives play a key supportive role for 
pregnant women with a cardiac condition in these multidisciplinary 
teams.
7  | MULTIDISCIPLINARY MANAGEMENT 
FOR BOTH C ARDIAC GROUPS
Women with cardiac disease and moderate or high risk of complica‐
tion in pregnancy have better outcomes when managed by a mul‐
tidisciplinary team—particularly, a pregnancy heart team (Arafeh & 
Baird, 2006; Regitz‐Zagrosek et al., 2018). This depends on good 
multidisciplinary collaboration between specialties such as congeni‐
tal cardiac imaging interventional catheterization, congenital cardiac 
surgery and anaesthesia, heart failure, transplantation, electrophysi‐
ology and reproductive and high‐risk pregnancy services. Naturally, 
their individual availability may be limited for women with more 
complex diseases (Cusimano, Pudwell, Roddy, Cho, & Smith, 2014; 
Rich‐Edwards, 2012).
The teamwork for multidisciplinary management across com‐
munity‐based programmes and tertiary care centres was the 
focus in Knight et al. (2016). This is a crucial research area, as most 
adults with CHD are not “cured” and require lifelong comprehen‐
sive care from specialists who have expertise in this complex arena 
(Rich‐Edwards, 2012). Women with previously undiagnosed heart 
disease during pregnancy require immediate referral to cardiolo‐
gists. However, high‐risk obstetric clinics may not necessarily be 
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supported by grown‐up congenital heart (GUCH) teams (Abdin, 
2006). Hatchett, McLaren, Corrigan, and Filer (2015) reported on 
GUCH nursing services and found patients expressed enhanced 
feelings of safety in coping with the demands of pregnancy and a 
heart condition, as well as satisfaction with the information pro‐
vided and continuity of care through important life transitions. 
Their research findings demonstrated the value and contribution 
of a specialist nursing service to women's experiences, particularly 
in terms of effective care coordination, monitoring and support 
(Hatchett et al., 2015). Given the recent reported deaths as a re‐
sult of atherosclerosis and ischaemic‐related heart conditions, there 
also needs to be some discussion on the services required and avail‐
able for women with ACS.
7.1 | Cardiac rehabilitation programmes
Merrigan (2009) stated that women have worse outcomes than men 
following midlife AMI, and therefore, innovative interventions re‐
sponsive to women's unique recovery need to be developed. It is 
recommended a woman traumatized by a cardiac event during preg‐
nancy have a psychologist and a mental health nurse included in the 
multidisciplinary team involved in follow‐up care (Merrigan, 2009). 
Tailored cardiac rehabilitation programmes that include midwives 
and lactation consultants who consider the issues of women with 
a new baby or the appropriateness of attending cardiac rehabilita‐
tion with older, post‐AMI patients are also recommended for women 
with AMI during pregnancy.
“Three Ps in a Pod” is an educational initiative that improves 
the care of women in pregnancy. An informative poster was distrib‐
uted to all women in acute medicine and emergency departments 
to assist clinicians in recognizing the key causes of maternal death 
(Knight et al., 2016). The three Ps represent “pregnancy,” “postnatal” 
and “pick it up” (both the phone and the problem) and help outline 
the key messages from the maternal mortality report published by 
MBRRACE‐UK (Royal College of Physicians & Surgeons of Glasgow, 
2019).
This clinical resource takes the initiative to address some of 
the factors contributing to maternal deaths from cardiac disease, 
including:
1. Failure to accurately diagnose cardiac problems.
2. Lack of early involvement of senior clinicians from obstetric and 
cardiology multidisciplinary teams, particularly when pregnant or 
postpartum women present to emergency departments.
3. Underestimation of the severity of the condition.
4. Lack of communication between multidisciplinary staff.
5. Absence of clear policies addressing cardiac problems.
6. Lack of pre‐pregnancy counselling available both in paediatric 
cardiology transition services and to women of child‐bearing age 
with known cardiac disease.
7. Lack of co‐location of obstetric and cardiac services, which jeop‐
ardizes interdisciplinary working and communication (Arafeh & 
Baird, 2006; Canobbio et al., 2017; Knight et al., 2016).
7.2 | Relevance to clinical practice
The Three Ps in a Pod clinical initiative in the UK highlights working 
as a team in multidisciplinary programmes to improve mothers’ care 
and save lives (Knight et al., 2016). Evidently, midwives play a key role 
during pregnancy and need to be appraised of the CVD observed in 
pregnancy, including its potential risks and anticipated problems and 
to consider their role within the continuum of care. Midwives are 
well equipped to assist in the normal birthing process but require 
additional knowledge to address the changing needs of women with 
CVD. Alternatively, a specialist midwife could ensure surveillance 
and management that includes prompt recognition and response to 
clinical deterioration (James et al., 2011). Future research is needed 
to explore the current continuum of care for women with CVD dur‐
ing pregnancy to identify gaps in clinical practice.
8  | CONCLUSION
Improving the detection of women with newly acquired cardiac con‐
ditions, and improving surveillance and maintaining the continuum 
of cardiac care for women with CHD will together improve the out‐
come for both mother and baby. As shown, the role of midwives in 
childbirth facilitates ongoing surveillance, risk assessment, parental 
health education, maternal awareness and self‐management to op‐
timize outcomes.
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